SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017171
Filing Date
2023-05-15
Accepted
2023-05-15 14:23:14
Documents
46
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 542165
2 ex31-1.htm EX-31.1 21623
3 ex31-2.htm EX-31.2 19961
4 ex32-1.htm EX-32.1 11109
  Complete submission text file 0001493152-23-017171.txt   3264391

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ptix-20230331.xsd EX-101.SCH 24081
6 XBRL CALCULATION FILE ptix-20230331_cal.xml EX-101.CAL 33731
7 XBRL DEFINITION FILE ptix-20230331_def.xml EX-101.DEF 147120
8 XBRL LABEL FILE ptix-20230331_lab.xml EX-101.LAB 245803
9 XBRL PRESENTATION FILE ptix-20230331_pre.xml EX-101.PRE 193087
40 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 398613
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 23920962
SIC: 2834 Pharmaceutical Preparations